全血复苏与儿科创伤患者末端器官功能障碍的降低有关
Erin Feeney1, Katrina M Morgan, Leah Furman
1From the Department of Surgery (E.F., K.M.M., L.F., C.L.), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and Department of Surgery (B.A.G.), University of Texas Southwestern, Dallas, Texas.
The journal of trauma and acute care surgery
|January 27, 2026
概括
在受伤的儿童中,低Titer组O全血 (WB) 复苏与较少的器官功能障碍病例有关. 这一发现表明WB可能是小儿创伤患者组分疗法的有益替代方案.
科学领域:
- 儿科创伤护理 儿童创伤护理
- 复苏医学 复苏医学 复苏医学
- 血液制品输血 输血 血液制品输血
背景情况:
- 低滴量组O全血 (WB) 越来越多地用于儿科创伤中的静血复苏.
- 在预防器官功能障碍方面,WB与组件疗法 (CT) 的比较有效性尚不清楚.
- 这项研究调查了WB输血与受伤儿童器官功能障碍之间的关联.
研究的目的:
- 为了确定WB输血是否与CT相比,在受伤儿童中器官功能障碍的发病率较低.
- 分析早期血液产品输血类型对受伤后器官功能障碍结果的影响.
主要方法:
- 使用TQIP数据库 (2020-2022) 对受伤儿童 (0-17岁) 的回顾性观察研究.
- 纳入标准:在ED到来4小时内接受血液制品,存活到72小时.
- 主要结局:器官功能障碍 (定义为机械通风,败血症,ARDS,肺炎,AKI,UTI,MI);使用调整为多个共变量的后勤回归分析.
主要成果:
- 在6237名受试者中,14.5%接受了WB. 器官功能障碍发生在38.8%的患者中.
- 调整后的分析显示,WB输血与器官功能障碍的几率降低有关 (OR,0.78;95% CI,0.61-0.98;p = 0.04).
- 敏感性分析表明生存偏差的影响最小.
结论:
- 用WB进行早期复苏独立地与受伤儿童的器官功能障碍减少有关.
- 研究结果支持WB作为在儿科创伤中潜在的有益的复苏策略.
- 需要进一步的前性和机理学研究来证实这些结果.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
212
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
271
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271
01:27Decreasing Function
264
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2 in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
264
01:29Decreased Body Temperature
1.0K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.0K